BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2006
View Archived Issues
Bone- and muscle-building effects seen with LGD-2941
Read More
Traditional Indian phytotherapy shows potential in AD therapy
Read More
Novel bone selective SARM increases BMD in gonadectomized male and female rats without virilization
Read More
Enrollment under way in phase II study of EcoNail for onychomycosis
Read More
NIAID grant supports MacroGenics' WNV antibody development work
Read More
Genentech and CGI collaborate in oncology and autoimmune diseases
Read More
NV-101 produces faster return of sensation following dental procedures
Read More
Phase III trial of NOVA-22007 in vernal keratoconjunctivitis completes enrollment
Read More
Eurand to apply technologies to GSK product
Read More
Plexxikon and Roche partner on PLX-4032
Read More
Baxter's candidate H5N1 pandemic influenza vaccine elicits functional antibodies to H5N1
Read More
LAB CGRP demonstrates broncho-protective effects in asthmatics
Read More
Kyorin and Merck & Co. report on their novel antibacterial oxazolidinones candidates
Read More
NIAID grant for smallpox drug candidate SIGA-246
Read More
Australian approval for Endeavor drug-eluting coronary stent
Read More
Swedish approval for phase IIa study of PBT-2 in early Alzheimer's disease
Read More
Recent patents disclose novel antiinfective agents
Read More
MultiCell announces strategic initiatives
Read More
Abbott patents novel RNA-directed RNA polymerase inhibitors
Read More
New treatment options for cancer covered in recent patent literature
Read More
Phoqus to advance Chronocort into phase I
Read More
deCODE suspends phase III study of DG-031 over formulation issues
Read More
Natural extract of tamarisk shows anticarcinogenic potential in rats
Read More
In vivo pharmacological profile of Pfizer's CE-129941 presented at the ICAAC meeting
Read More
Novel antibacterial compound margaucin effective against multidrug-resistant Gram-positive pathogens
Read More
New preclinical data on peramivir reported at ICAAC
Read More
Further preclinical data on Migenix's antibacterial product candidate MX-2401
Read More
Atripla submitted for E.U. approval
Read More
Zolinza approved for cutaneous manifestations in CTCL patients
Read More
Brovana approved for COPD
Read More
Risperdal approved for irritability associated with autistic disorder
Read More
Torisel filed for advanced renal cell carcinoma in U.S. and E.U.
Read More
